Franklin Templeton Investment Funds Franklin Biotechnology Discovery Fund Klasse I (acc) EUR-H1/ LU0889565759 /
| NAV10/3/2024 | Chg.-0.4100 | Type of yield | Investment Focus | Investment company |
|---|---|---|---|---|
| 26.0300EUR | -1.55% | reinvestment | Equity Worldwide | Franklin Templeton ▶ |
Monthly performance
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013 | - | - | 7.18 | 6.06 | 2.85 | -0.93 | 14.69 | -1.48 | 9.47 | -5.77 | 6.77 | 3.41 | - |
| 2014 | 11.94 | 6.66 | -9.83 | -7.17 | 3.04 | 8.20 | -0.71 | 13.06 | -2.11 | 8.19 | 1.15 | 1.92 | +36.54% |
| 2015 | 5.89 | 5.34 | 3.16 | -5.16 | 9.78 | 0.24 | 2.17 | -9.61 | -12.59 | 6.23 | 4.41 | -0.72 | +6.76% |
| 2016 | -22.76 | -6.09 | 4.24 | 3.59 | 6.18 | -7.73 | 10.08 | -1.66 | 5.39 | -11.01 | 8.77 | -3.42 | -18.14% |
| 2017 | 5.53 | 7.75 | -1.31 | 0.39 | -7.02 | 8.71 | 2.52 | 4.69 | 0.86 | -7.98 | -1.02 | 2.95 | +15.59% |
| 2018 | 5.60 | -3.26 | -2.90 | -3.09 | 4.98 | 0.81 | 1.88 | 4.15 | -1.91 | -15.00 | 3.03 | -11.81 | -18.22% |
| 2019 | 13.45 | 4.64 | -0.59 | -5.35 | -2.72 | 11.84 | -4.72 | -5.40 | -5.77 | 10.59 | 10.50 | 3.20 | +30.18% |
| 2020 | -4.94 | 0.57 | -9.16 | 13.81 | 9.77 | 3.15 | 0.48 | 0.04 | 2.60 | -4.32 | 11.51 | 3.39 | +27.31% |
| 2021 | 0.18 | 1.41 | -6.32 | 0.70 | -5.60 | 5.69 | -5.06 | 4.86 | -4.74 | -1.48 | -7.62 | -0.09 | -17.54% |
| 2022 | -9.84 | -3.61 | 4.48 | -8.67 | -6.66 | 3.15 | 2.89 | -0.57 | -1.47 | 4.09 | 6.44 | -3.98 | -14.38% |
| 2023 | 4.80 | -4.86 | 0.45 | 3.64 | -3.66 | 1.20 | 2.62 | -1.01 | -3.50 | -5.79 | 3.85 | 19.05 | +15.54% |
| 2024 | 4.93 | 8.29 | -1.67 | -7.12 | 1.92 | 2.54 | 5.98 | 1.81 | -1.92 | -1.88 | - | - | - |
Calculated values
| YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
|---|---|---|---|---|---|
| Volatility | 18.51% | 17.76% | 20.06% | 22.07% | 24.96% |
| Sharpe ratio | 0.75 | 0.27 | 1.59 | -0.09 | 0.20 |
| Best month | +19.05% | +5.98% | +19.05% | +19.05% | +19.05% |
| Worst month | -7.12% | -7.12% | -7.12% | -9.84% | -9.84% |
| Maximum loss | -13.97% | -8.95% | -13.97% | -36.27% | -47.03% |
| Outperformance | -10.08% | - | -10.50% | -16.54% | -25.06% |
All quotes in EUR
Share classes
| Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
|---|---|---|---|---|---|
| Franklin Templeton Investment Fu... | reinvestment | 49.4600 | +35.99% | +7.20% | |
| Franklin Templeton Investment Fu... | reinvestment | 28.0900 | +35.64% | +8.79% | |
| Franklin Templeton Investment Fu... | reinvestment | 44.7600 | +26.51% | +14.83% | |
| Franklin Templeton Investment Fu... | reinvestment | 41.0100 | +29.21% | +4.22% | |
| F.Biotechnology Dis.Fd.F USD | reinvestment | 13.6700 | +35.48% | +5.89% | |
| F.Biotechnology Dis.Fd.N-H1 PLN | reinvestment | 10.3200 | +35.26% | - | |
| Franklin Templeton Investment Fu... | reinvestment | 69.2100 | +37.92% | +11.88% | |
| Franklin Templeton Investment Fu... | reinvestment | 26.0300 | +35.15% | +4.12% | |
| F.Biotechnology Dis.Fd.W USD | reinvestment | 21.6200 | +37.88% | +11.73% | |
| F.Biotechnology Dis.Fd.Z USD | reinvestment | 16.2300 | +37.43% | +10.71% | |
| Franklin Templeton Investment Fu... | reinvestment | 35.8300 | +35.72% | +6.64% | |
| Franklin Templeton Investment Fu... | reinvestment | 16.9200 | +30.56% | -2.98% | |
| F.Biotechnology Dis.Fd.A-H1 EUR ... | reinvestment | 12.6000 | +34.04% | +1.53% | |
| Franklin Templeton Investment Fu... | reinvestment | 43.4000 | +36.74% | +9.07% |
Performance
| YTD | +12.59% | ||
|---|---|---|---|
| 6 Months | +3.95% | ||
| 1 Year | +35.15% | ||
| 3 Years | +4.12% | ||
| 5 Years | +48.40% | ||
| 10 Years | +38.38% | ||
| Since start | +160.30% | ||
| Year | |||
| 2023 | +15.54% | ||
| 2022 | -14.38% | ||
| 2021 | -17.54% | ||
| 2020 | +27.31% | ||
| 2019 | +30.18% | ||
| 2018 | -18.22% | ||
| 2017 | +15.59% | ||
| 2016 | -18.14% | ||
| 2015 | +6.76% | ||
